261 related articles for article (PubMed ID: 10377671)
21. [Progress in the treatment of colorectal cancer].
Sasaki T; Maeda Y; Kobayashi T; Omuro Y; Takeda N; Ohmuro T
Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():129-38. PubMed ID: 10410667
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant and palliative treatment of colorectal cancer with fluorinated pyrimidines. A pharmacological and clinical review.
Gustavsson B; Hafström L
Acta Chir Scand Suppl; 1981; 504():1-28. PubMed ID: 6176091
[No Abstract] [Full Text] [Related]
23. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
Grothey A; Sargent DJ
J Clin Oncol; 2005 May; 23(15):3311-3. PubMed ID: 15908645
[No Abstract] [Full Text] [Related]
24. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
Chua YJ; Zalcberg JR
Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of postoperative adjuvant chemotherapy for colorectal cancer].
Nozoe Y; Ogata Y; Miyagi Y; Nakagawa M; Matono K; Sasatomi T; Araki Y; Shirouzu K
Gan To Kagaku Ryoho; 2002 Jan; 29(1):67-72. PubMed ID: 11816480
[TBL] [Abstract][Full Text] [Related]
26. Severe and fatal toxic effects observed in treatment with high- and low-dose leucovorin plus 5-fluorouracil for colorectal carcinoma.
Grem JL; Shoemaker DD; Petrelli NJ; Douglass HO
Cancer Treat Rep; 1987 Nov; 71(11):1122. PubMed ID: 3499982
[No Abstract] [Full Text] [Related]
27. NCCN guideline updates: colon and rectal cancers, version 1.2004.
National Comprehensive Cancer Network
J Natl Compr Canc Netw; 2004 Jul; 2(4):284-5. PubMed ID: 19795595
[No Abstract] [Full Text] [Related]
28. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
Uemura N; Yamada Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
[TBL] [Abstract][Full Text] [Related]
29. [Assessment of the quality of life during adjuvant chemotherapy of colorectal cancer].
Bellemare S; Heyen F; Martin G; Dubé S
Ann Chir; 1998; 52(8):711-5. PubMed ID: 9846419
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of colorectal cancers. Recommendations of the French Foundation of Digestive Cancerology].
Gastroenterol Clin Biol; 1991; 15(4):374-5. PubMed ID: 2060755
[No Abstract] [Full Text] [Related]
31. [Results of adjuvant and palliative chemotherapy of carcinoma of the large intestine and rectum].
Andrysek O; Cermák J; Krusina L; Linhart O; Nĕmec I; Pacák K; Slavatová E; Svarcová H
Cas Lek Cesk; 1986 May; 125(22):672-6. PubMed ID: 2423246
[No Abstract] [Full Text] [Related]
32. Colorectal cancer.
Maghfoor I
Lancet; 1999 Mar; 353(9157):1013. PubMed ID: 10459936
[No Abstract] [Full Text] [Related]
33. Pancreatic metastasis from colon carcinoma treated with radiotherapy with palliative benefit.
Saif MW; Kaley K
JOP; 2010 Nov; 11(6):644-5; author reply 650. PubMed ID: 21068505
[No Abstract] [Full Text] [Related]
34. Longitudinal assessment of quality of life in rectal cancer patients with or without stomas following primary resection.
Yau T; Watkins D; Cunningham D; Barbachano Y; Chau I; Chong G
Dis Colon Rectum; 2009 Apr; 52(4):669-77. PubMed ID: 19404073
[TBL] [Abstract][Full Text] [Related]
35. UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
Vormittag L; Kornek GV; Gruhsmann B; Lenauer A; Föger A; Depisch D; Lang F; Scheithauer W
Anticancer Drugs; 2007 Jul; 18(6):709-12. PubMed ID: 17762401
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of rectal cancer and follow up].
Charúa-Guindic L
Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():126-31. PubMed ID: 18277500
[No Abstract] [Full Text] [Related]
37. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Taal BG; Van Tinteren H; Zoetmulder FA;
Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
[TBL] [Abstract][Full Text] [Related]
39. [Retrospective analysis on efficacy and toxicity of 5-fluorouracil (5-FU) and l-leucovorin (l-LV) in advanced or recurrent colorectal cancer].
Chiba N; Yoshioka T; Kato S; Takahashi S; Shibata H; Kato S; Sakayori M; Otsuka K; Kakudo Y; Ohori H; Yamaura G; Takahashi M; Yasuda K; Ishioka C
Gan To Kagaku Ryoho; 2005 Jul; 32(7):991-5. PubMed ID: 16044961
[TBL] [Abstract][Full Text] [Related]
40. [Progress in adjuvant therapy for colorectal cancer].
Kohnoe S; Kakeji Y; Maehara Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2488-97. PubMed ID: 12506471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
